Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29037
The License relate to three CTP (Carboxyl Terminal Peptide) patents and expanded the field of use to all natural and non-natural therapeutic proteins and peptides (other than LH, FSH and hCG). Under the License Agreement, the Licensor has the right to sub-License the Licensed patents. The License Agreement terminates in 2018 when the last of the patents Licensed to us under the License Agreement expires, unless terminated earlier. Pursuant to our License Agreement with the University, we have obtained an exclusive License to the key CTP patents that have been issued by the U.S. Patent and Trademark Office – U.S. #5,712,122, U.S. #5,759,818 and U.S. #6,225,449.
IPSCIO Record ID: 790
Subject to the provisions of this Agreement, Licensor hereby grants to Licensee, for the Term, an exclusive, sub-licensable license to use the Licensed Patents and Technical Information to manufacture clinical grade gonadotropin hormones including FSH in the Manufacturing Territory for sale within the Sales Territory in the Field of Use.
Licensed Patents as used herein means any and all patents, patent applications or utility models owned by Licensor during the Term of this Agreement, which are either pending or in force during the Term and relate to any Licensed Product, or any item of Technical Information. Below is a current list of Licensed Patents. Licensed Products as used herein means manufacturing methods for purification of gonadotropins &/or methods to generate crude mixtures of gonadotropins for further purification by use of licensed methods and all components and related products which are designed or developed by or for Licensee utilizing Technical Information and Licensed Patents as identified is this Agreement.
Sublicense. Subject to the provisions of this Agreement, Licensor hereby grants to Licensee the right to sublicense the rights granted in Article 2.1. Licensee may sublicense the manufacturing rights licensed to it under Section 2.1 upon the prior written consent of the Licensor.
1. United States Patent Number 5,990,288, Method for Purifying FSH.
2. United States Patent Number 6,458,593 B1, Immortalized Cell Lines and Methods of Making The Same.
1. FSH produced through use of US Patent no. 5,990,288.
2. FSH, LH and/or hCG produced through use of US Patent no. 6,458,593 B1.
3. FSH, LH and/or hCG produced through use of US Patent no. 6,458,593 B1 and subsequently purified through use of US Patent no. 5,990,288.
4. FSH, LH and/or hCG produced through technology and know-how transferred from the Licensor to the Licensee/Sub-licensee.
5. Formulations of fertility drugs used to treat infertility produced through technology and know-how transferred from the Licensor to the Licensee/Sub-licensee.
6. Licensed Products described in Nos. 4 & 5 above, are to be mutually agreed as such by both Licensor and Licensee.
Licensee desires to manufacture, or have manufactured by a third party contract manufacturing organization, gonadotropin hormones for use in the treatment of infertility using Licensed Patents, and Technical Information of Licensor relating to the manufacture of gonadotropin hormones. Licensee desires to obtain rights to use Licensor's US Patents, and an option to a pending patent application for the commercial production of clinical grade gonadotropin hormones and, in addition, the Licensor's intellectual property related to generation of crude materials containing gonadotropin hormones from certain cellular sources.
IPSCIO Record ID: 27095
IPSCIO Record ID: 29194
The Animal Subfield shall include all therapeutic treatment in non-humans.
The Diagnostic Subfield shall include all diagnostics in humans and non-humans.
IPSCIO Record ID: 2219
Licensed Patent(s) shall mean United States Letters Patent No. 5,591,645. Patents relate to Rapid Manual Tests for hCG and LH analytes. Human chorionic gonadotropin or human chorionic gonadotropin (hCG) is a glycoprotein hormone produced in pregnancy that is made by the developing embryo after conception and later by the syncytiotrophoblast (part of the placenta).